Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ABSI

ABSI News

Newswire

10:51

Absci shares surge 10.49% intraday as AI-designed antibody ABS-201 enters clinical evaluation for androgenetic alopecia.

08:30

Absci Announces First Participants Dosed in Phase 1/2a Headline Trial

08:08

Absci's ABS-201 anti-PRLR antibody trial begins with first healthy volunteers dosed.

19:25

Absci Corporation Presents at Jefferies London Healthcare Conference 2025 Transcript

00:00

Absci's Lower Per-Share Loss: Efficiency or Temporary Shift?

View More

About ABSI

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More